ValuEngine upgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a buy rating in a report issued on Friday, ValuEngine reports.

Several other brokerages have also issued reports on EDAP. TheStreet lowered shares of Timkensteel from a c- rating to a d+ rating in a research note on Monday, June 17th. Zacks Investment Research raised shares of Golub Capital BDC from a hold rating to a buy rating and set a $20.00 price objective on the stock in a research report on Tuesday, July 16th. Finally, HC Wainwright set a $4.00 price objective on shares of Uranium Energy and gave the company a buy rating in a research report on Tuesday, June 11th.

Shares of Edap Tms stock opened at $3.32 on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.97 and a current ratio of 2.40. The stock has a 50-day simple moving average of $2.73. The company has a market cap of $89.89 million, a price-to-earnings ratio of 166.00 and a beta of 1.94. Edap Tms has a 1 year low of $1.35 and a 1 year high of $5.42.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, May 15th. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $11.50 million during the quarter, compared to analyst estimates of $13.25 million. Edap Tms had a negative net margin of 0.36% and a negative return on equity of 1.13%. Equities analysts anticipate that Edap Tms will post 0.08 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Edap Tms stock. Hilton Capital Management LLC acquired a new stake in shares of Edap Tms SA (NASDAQ:EDAP) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 25,000 shares of the medical equipment provider’s stock, valued at approximately $75,000. Hilton Capital Management LLC owned about 0.09% of Edap Tms as of its most recent filing with the SEC. 10.32% of the stock is currently owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

See Also: Liquidity

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with's FREE daily email newsletter.